A detailed history of Rhumbline Advisers transactions in Tela Bio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 2,499 shares of TELA stock, worth $6,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,499
Previous 15,095 83.44%
Holding current value
$6,297
Previous $85,000 87.06%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$4.39 - $6.36 $55,296 - $80,110
-12,596 Reduced 83.44%
2,499 $11,000
Q1 2024

May 09, 2024

BUY
$5.3 - $7.61 $1,743 - $2,503
329 Added 2.23%
15,095 $85,000
Q4 2023

Feb 08, 2024

BUY
$4.5 - $7.51 $801 - $1,336
178 Added 1.22%
14,766 $97,000
Q3 2023

Nov 09, 2023

BUY
$7.85 - $10.68 $6,908 - $9,398
880 Added 6.42%
14,588 $116,000
Q2 2023

Aug 08, 2023

BUY
$9.23 - $11.23 $126,524 - $153,940
13,708 New
13,708 $138,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $48.3M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.